Quest Diagnostics Inc (DGX) Total liabilities 2016–2025
Quest Diagnostics Inc (DGX) total liabilities at each fiscal year-end, per SEC filings.
$9.1BFY2025 · since FY2016: $5.5B → $9.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9.1B | -3.4% |
| FY2024 | $9.4B | +21.5% |
| FY2023 | $7.7B | +11.1% |
| FY2022 | $6.9B | -3.1% |
| FY2021 | $7.2B | -1.4% |
| FY2020 | $7.3B | +0.9% |
| FY2019 | $7.2B | +24.5% |
| FY2018 | $5.8B | +3.7% |
| FY2017 | $5.6B | +2.0% |
| FY2016 | $5.5B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice